Wholesale
Wholesale pricing available
Qualify for automatic discounts at checkout when your order of wholesale eligible items hits a volume threshold.
$2,000+15% off$4,000+20% off$6,000+25% off$10,000+40% offFull wholesale details →
$392.78$413.45
($78.56 / Item) — Save $20.67 (5% off)
In stock — dispatches within 24h, tracked
TB-500 10mg. Used to support tissue repair, muscle recovery, joint and tendon health, and overall healing. Lab tested, discreetly shipped across Canada.
FormatLyophilized Vial
ConcentrationDependent on reconstitution with BAC water
Pack Size Selected: 5 Pack
Pay with Interac e-Transfer or Crypto
Wholesale pricingCost per item by order value
$2,000+15% off$333.86per item
$4,000+20% off$314.22per item
$6,000+25% off$294.59per item
$10,000+40% off$235.67per item
Estimated prices based on the current product or selected option price. Tiers use your eligible wholesale subtotal before the wholesale discount. Discounts apply automatically in your cart.
Choose an option to see its wholesale prices.
HPLC verified. COA on file for this batch
Ships from within Canada; No Customs
Discreet plain packaging; always
24h dispatch; Tracked Delivery
TB-500 (Thymosin Beta 4 fragment) is a synthetic analogue of Thymosin Beta-4, a naturally occurring peptide involved in actin regulation and cell motility found in virtually all human and animal cells. Hudson Science’s standalone 10mg lyophilized vial presents a single unit option within CSD’s TB-500 range. Sitting between the individual vial format and the multi pack presentations, suited to researchers initiating TB-500 protocols, evaluating compound performance before committing to larger supply volumes, or requiring a single supplementary vial to extend an existing research timeline.
TB-500’s primary research mechanism centers on its LKKTETQ actin binding domain, the tetrapeptide sequence that mediates G actin sequestration and upregulation of actin polymerization dynamics. By enhancing actin driven cell motility, TB-500 promotes cellular migration to injury sites, supports new blood vessel formation through a complementary angiogenic mechanism to BPC-157’s nitric oxide pathway activity, and modulates the inflammatory response in damaged tissue. This actin mediated mechanism operates independently from growth factor receptor pathways and FAK paxillin signaling. The distinct but synergistic relationship between TB-500 and BPC-157’s mechanisms explaining their status as the most frequently co studied peptide pair in preclinical tissue repair literature.
CSD stocks TB-500 across the most comprehensive format and supply volume range in our peptide catalogue: this Hudson Science 10mg single vial, the Hudson Science 10mg 5 pack at 50mg total, the iLab Pharma 10mg 10 pack at 100mg total, and inclusion across the iLab Pharma Wolverine Stack vial, F40 Biotech Wolverine Pen, F40 Biotech Glow Pen, F40 Biotech KLOW Pen, and iLab Pharma KLOW Protocol combination formats. Researchers can select single vial format for protocol initiation and evaluation, scale to multi pack supply for extended standalone protocols, or source TB-500 within combination formats for BPC-157 co administration and multi peptide blend research.
Hudson Science formulations are stocked by Canada Steroid Depot following the same rigorous third party lab verification process applied to every product in our range. Each batch is tested for concentration accuracy and purity before being made available, with COA documentation available on request. CSD’s sourcing standards apply uniformly across all manufacturers we carry, and Hudson Science’s TB-500 meets those standards consistently. All orders ship discreetly across Canada in plain, unmarked packaging with no identifying information on the exterior.
Reconstitute with bacteriostatic water prior to use. Store lyophilized peptide at 2–8°C away from direct light. Once reconstituted refrigerate and use within 28 days. Intended for research purposes only.
Commonly researched alongside BPC-157 in tissue repair and recovery protocols. Browse CSD’s full peptide range for complete sourcing.
TB-500 is a synthetic research peptide derived from a biologically active region of thymosin beta 4. It is associated with the N-acetylated LKKTETQ sequence and is primarily investigated in research involving cellular migration, angiogenesis, tissue repair, connective tissue biology, and inflammatory signaling. This product contains 10mg of lyophilized TB-500 in a single vial for laboratory research.
TB-500 is primarily associated with regenerative and tissue repair research derived from the biological activity of thymosin beta 4. Research in this area has examined cell migration, formation of new blood vessels, wound healing, connective tissue organization, muscle repair, inflammatory signaling, and recovery following tissue injury. Much of the evidence supporting these mechanisms comes from thymosin beta 4 and related peptide fragment research rather than established therapeutic use of commercial TB-500 products.
Thymosin beta 4 is a naturally occurring 43 amino acid peptide involved in actin regulation, cellular migration, angiogenesis, and tissue repair. TB-500 is a synthetic peptide associated with the LKKTETQ actin binding region of thymosin beta 4 rather than the complete native molecule. Because this region contributes to several of thymosin beta 4's biological activities, TB-500 is commonly discussed alongside thymosin beta 4 research, although the two should not be treated as chemically identical.
Thymosin beta 4 related research has demonstrated important roles in cellular migration and angiogenesis, both of which are central to tissue repair. Experimental studies have reported increased endothelial cell migration, blood vessel formation, re epithelialization, and wound repair. The LKKTETQ region associated with TB-500 has also been identified as an important actin binding motif involved in the angiogenic activity of thymosin beta-4.
Yes! This batch is HPLC tested to verify TB-500 identity and content accuracy at 10mg per vial. A certificate of analysis is available.
